Novel Coronavirus (COVID-19)
About the COVID-19 Novel Coronavirus
Follow the links below to find resources related to COVID-19 for all facilities, including the NETEC webinar series, PPE use and conservation guidance documents, education and training resources, preparedness resources, research on respiratory pathogens and airborne transmission, clinical guidance documents, documents on ambulatory PPE, and other research resources. Click here for items on COVID-19 and pediatrics. Scroll for the COVID-19 map, key updates, and new NETEC resources. You can go to the WHO COVID-19 pages and the CDC COVID-19 pages for additional resources.
New NETEC Resources:
Updates and Map
Find more information on Coronavirus on the Lancet's Coronavirus page. See updates on COVID-19 on the WHO Novel Coronavirus (COVID-19) page with Situation Reports and Disease Outbreak News, and see the updated Geographical distribution of COVID-19 cases within China and globally on the European Centre for Disease Prevention and Control page. Map below created by Johns Hopkins (if the map does not load below, you can view it on the Johns Hopkins page).
- On December 22, 2021 the U.S. Food and Drug Administration issued an EUA for Panlovid for the treatment of mild-to-moderate COVID-19 in adults and some pediatric patients. In response, the Society for Maternal-Fetal Medicine (SMFM) stated "SMFM supports the use of Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for treatment of pregnant patients with COVID-19 who meet clinical qualifications." (SMFM Read More)
- On October 20, 2021, the FDA amended the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose, for all three approved vaccines and as a heterologous (or “mix and match”) booster dose (see detailed terms: FDA).
- On August 23, 2021, the FDA approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older (FDA). The FDA authorized Pfizer COVID-19 vaccine EUA for adolescents 12-15 years of age May 10, 2021 (FDA). The FDA approved Pfizer's EUA for 16+ on December 11, 2020 (FDA).
- The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM), leading organizations in obstetric care, recommend all pregnant individuals be vaccinated against COVID-19 (ACOG). ACOG also recommends lactating individuals be vaccinated (ACOG).
- New COVID-19 variants are circulating globally. Find out more from the CDC.
- Follow the number of vaccination doses distributed and administered in the USA on the CDC's dashboard. The Moderna developed vaccine was given FDA EUA approval on Friday December 18, 2020 (FDA). The FDA approved the Janssen/Johnson & Johnson vaccine Feb. 27, 2021 EUA in the USA (FDA). Development continues to advance on coronavirus vaccines, follow the development with the Coronavirus Vaccine Tracker managed by The New York Times.
- The NIH COVID-19 Treatment Guidelines summarizes clinical data for treatment of COVID-19 (CDC).
- On 31 December 2019 the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) in Wuhan City, China. A novel coronavirus (2019-nCoV) was identified by Chinese authorities on 7 January 2020 (WHO). On 11 February the name of the virus was announced as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the disease as coronavirus disease (COVID-19) (WHO).
CDC Novel Coronavirus Updates
Cases in the U.S....
Wed, 19 Jan 2022CDC COVID Data Tracker - Cases and Deaths by State
Reporting COVID-19 Vaccinations in the United States...
Wed, 19 Jan 2022Information on COVID-19 vaccination data reported in CDC's COVID Data Tracker.
Guidance for SARS-CoV-2 Point-of-Care Testing...
Wed, 19 Jan 2022This CDC webpage provides guidance on the regulatory requirements for SARS-CoV-2 POC testing, using POC tests safely, and information on reporting POC test results.